NanoGroup S.A.

Warsaw Stock Exchange NNG.WA

NanoGroup S.A. Gross Profit Margin for the year ending December 31, 2023: -3,913.67%

NanoGroup S.A. Gross Profit Margin is -3,913.67% for the year ending December 31, 2023, a -12,579.12% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • NanoGroup S.A. Gross Profit Margin for the year ending December 31, 2022 was 31.36%, a -49.62% change year over year.
  • NanoGroup S.A. Gross Profit Margin for the year ending December 31, 2021 was 62.25%, a -34.79% change year over year.
  • NanoGroup S.A. Gross Profit Margin for the year ending December 31, 2020 was 95.46%, a 0.69% change year over year.
  • NanoGroup S.A. Gross Profit Margin for the year ending December 31, 2019 was 94.81%, a 23.40% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Warsaw Stock Exchange: NNG.WA

NanoGroup S.A.

CEO Mr. Przemyslaw Daniel Mazurek
IPO Date March 14, 2018
Location Poland
Headquarters Rakowiecka 36
Employees 46
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

NanoGroup S.A. operates as a biotechnology company. It develops and licenses early-stage biotechnology and medical projects in the areas of oncology, transplantology, and blood donations to international biotech companies and pharmaceutical companies. NanoGroup S.A was incorporated in 2016 and is based in Warsaw, Poland.

StockViz Staff

January 15, 2025

Any question? Send us an email